Canada markets closed

PFE Jan 2024 57.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
14.050.00 (0.00%)
As of 04:58PM EDT. Market open.
Full screen
Previous Close14.05
Expire Date2024-01-19
Day's Range14.05 - 14.05
Contract RangeN/A
Open Interest16
  • Motley Fool

    Could This Move by Johnson & Johnson Equal Billions for Moderna?

    What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)? Last week, however, Johnson & Johnson said it would discontinue its adult RSV program. Could the J&J news eventually translate into billions of dollars for Moderna?

  • Motley Fool

    3 Surprisingly Underrated Stocks to Buy in April

    Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.

  • Motley Fool

    If You Invested $25,000 in Pfizer in 2020, This Is How Much You Would Have Today

    Investing in top COVID-19 vaccine maker Pfizer (NYSE: PFE) seems like it should have made you rich if you bought the stock in March 2020. On March 2, 2020, Pfizer's stock was selling for $33 a share. It would be nearly a year before Pfizer had an approved COVID-19 vaccine, which was produced in partnership with BioNTech.